(Reuters) - Allergan Inc is in buyout talks with Actavis Plc in addition to Salix Pharmaceuticals Ltd , CNBC reported on Wednesday, as the company tries to fend off a takeover attempt by Valeant Pharmaceuticals Inc .
ALLERGAN (AGN.NY)has questioned the sustainability of Valeant's growth and business model and "opaque" financial disclosures.
Valeant said on Wednesday that such concerns were "completely unfounded."
"In the third quarter, we expect our results to be better than consensus on revenue, and better than the guidance we provided in our second quarter earnings call for Cash EPS, organic growth, restructuring charges and adjusted cash flow from operations," Valeant Chief Executive Michael Pearson said in a letter to Allergan's board.
(Reporting by Vidya L Nathan; Editing by Saumyadeb Chakrabarty)
Relacionados
- La UE compromete 215 millones adicionales para la ayuda a las víctimas de la guerra en Siria
- Aviones de guerra lanzan diez ataques aéreos contra posiciones yihadistas en el noreste sirio
- Guerra de amor 'tuitero' entre Jessica Bueno y Kiko Rivera
- El modernismo y la Guerra Civil ganan protagonismo en la visita del MNAC
- El periodista británico secuestrado dice que la guerra contra el Estado Islámico será como Vietnam
